Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Synaptive Medical

Explore full profile

Medical devices, medical imaging and informatics

Toronto, CanadaFounded 2012Health Tech & Medtech
Valuation $100–500M Latest valuation · 2019
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Synaptive Medical and the history behind them.

About Synaptive Medical

Synaptive Medical, founded in 2012 by Cameron Piron and Wes Hodges, is a Toronto-based medical technology company focused on improving neurosurgical outcomes. Piron, an engineer with a background in medical biophysics, previously co-founded and led Sentinelle Medical, a firm specializing in MRI-based imaging, which was acquired in 2010. This experience in medical imaging provided the foundation for a much larger vision, which materialized as Synaptive Medical, a fully vertically integrated company that develops entire MRI and robotic surgery systems.

Read full description

The company operates in the global medical technology market, providing an integrated suite of solutions for hospitals, surgeons, and radiologists, with a primary focus on neurosurgery, as well as applications in spine, ENT, and plastics/reconstructive procedures. Its business model is based on developing and selling fully integrated software and hardware solutions that cover the entire surgical process, from pre-operative planning to intra-operative execution and post-surgical care. This approach addresses challenges in surgical planning, navigation, and visualization.

Synaptive's product portfolio is designed to work in synergy, beginning with a proprietary point-of-care MRI system optimized for neurological scans. This system requires less space and does not need helium for cooling, offering cost advantages. The imaging data integrates with the 'Modus Plan' software, which uses automatic tractography segmentation to create patient-specific 3D maps of the brain's neural pathways. During surgery, 'Modus Nav' provides accurate navigation using this data, while the 'Modus X' robotic exoscope offers high-resolution 4K 3D visualization, allowing surgeons to see critical structures with greater clarity and from a more ergonomic position. This integrated workflow aims to enhance clinical decision-making and precision at every stage of care. Keywords: neurosurgery, medical imaging, robotic surgery, surgical navigation, medical devices, surgical planning, MRI systems, tractography, exoscope, MedTech

Source: Dealroom company data

At a glance

Status
Operational
Founded
2012
Headquarters
Toronto, Canada
Employees
95
Open positions
1
Dealroom signal
61.8/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Neurology, Spinout, DT and LS, science-based
Technology
Artificial Intelligence, Deep Tech
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company, latest Mar 2015
Capital deployed
Preferred round
ACQUISITION

Latest news

Press, funding announcements and product moves mentioning Synaptive Medical.

See all news

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jul 2025 $0 Undisclosed
DEBTDebt Mar 2023 $50M Export Development Canada
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Synaptive Medical website traffic

Latest recorded traffic for Synaptive Medical is 5K monthly website visits, up 51.5% over the last three months. Synaptive Medical's team declined 18.1% over the past year.

Latest monthly visits5K 3-month web change+51.5% 1-year team growth-18.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later2 investors entered at this stage

  • Espresso Capital
  • Export Development Canada

Other known investors1 additional known investor

  • University of Waterloo
Team profiled 23 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇨🇦 Canada70%
🇺🇸 United States27.8%
🇬🇧 United Kingdom1.1%
🇦🇺 Australia1.1%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Synaptive Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Synaptive Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.